Key result
The Evolut Pro and FX transcatheter heart valve systems provide good clinical outcomes, excellent hemodynamic performance, and technical enhancements for valve positioning and vascular access.
Why the study?
Continuous iterations of the CoreValve system have been developed to improve procedural success and reduce periprocedural complications.
The Evolut Pro and FX self-expanding TAVR systems offer good clinical outcomes, excellent hemodynamics, and technical enhancements for improved procedural success.
Supports Evolut TAVR use; leaves open randomized comparisons of Pro versus FX.
INTRODUCTION: Since the initial experience with the CoreValve (Medtronic, Minneapolis, Minnesota), there have been continuous iterations of this valve system in order to improve procedural success and reduce periprocedural complications. The Evolut Pro, Pro+, and FX are the latest generations of this transcatheter heart valve (THV). AREAS COVERED: This review paper aims to analyze the main characteristics and clinical evidence about the Evolut Pro THV and summarize the main iterations of the newer generation Evolut FX valve system. EXPERT OPINION: The Evolut Pro system has been associated with good clinical outcomes and excellent valve hemodynamic performance including reduced rates of paravalvular leaks. Technical enhancements to improve valve positioning, orientation, and vascular access have been implemented in the newer generation Evolut FX system.
No takes yet. Share an insight, caveat, or question.
Panagides et al. (2022) conducted a review in Transcatheter aortic valve replacement. Evolut Pro and Evolut FX transcatheter heart valve systems was evaluated. The Evolut Pro and FX transcatheter heart valve systems provide good clinical outcomes, excellent hemodynamic performance, and technical enhancements for valve positioning and vascular access.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: